New Delhi, March 8 (IANS) A US-based subsidiary of Cipla has recalled more than 400 cartons of a generic anti-cancer medicine due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).In its latest enforcement report, the US health regulator said that Cipla USA, Inc, based in Warren, New Jersey, is recalling certain batches of Nilotinib Capsules in two strengths — 150 mg and 200 mg.The recall involves 271 cartons of one batch and 164 cartons of another batch of the …
Latest Warren News & Updates
New Delhi, Jan 26 (IANS) Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).In its Enforcement Report, the US health regulator said the US-based arm of Mumbai-headquartered Sun Pharma is recalling more than 26,000 bottles of a generic medicine used to treat dandruff and skin conditions that cause inflammation and itching.Sun…